The role of immune checkpoint molecules in cancers

Immune checkpoint molecules play a central role in regulating T cell function, maintaining immune homeostasis, and facilitating tumor immune evasion, making them critical targets in cancer immunotherapy. This review provides a comprehensive overview of the structural characteristics and signaling mechanisms of key co-inhibitory and co-stimulatory molecules, and their immunoregulatory roles in both solid tumors and hematological malignancies. Recent advances in the clinical application of immune checkpoint inhibitors, combination therapy strategies, and mechanisms of resistance are discussed. Furthermore, the importance of multi-target combinatorial approaches and personalized immune modulation is emphasized, offering valuable insights and directions for optimizing cancer immunotherapy strategies.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-01-14
DOI
https://doi.org/10.3389/fimmu.2025.1674818
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The role of immune checkpoint molecules in cancers

Lei Zhu, Mingqing Zhou, Zhiyun Guo, Hao Wang et al.
Frontiers in Immunology
Cancer Immunotherapy and Biomarkers
article

The role of immune checkpoint molecules in cancers

Lei Zhu, Mingqing Zhou, Zhiyun Guo, Hao Wang, Junjie Xu, Hailin Tang, Zhaokuan Zheng, Meilan Zhang
article en

Abstract

Immune checkpoint molecules play a central role in regulating T cell function, maintaining immune homeostasis, and facilitating tumor immune evasion, making them critical targets in cancer immunotherapy. This review provides a comprehensive overview of the structural characteristics and signaling mechanisms of key co-inhibitory and co-stimulatory molecules, and their immunoregulatory roles in both solid tumors and hematological malignancies. Recent advances in the clinical application of immune checkpoint inhibitors, combination therapy strategies, and mechanisms of resistance are discussed. Furthermore, the importance of multi-target combinatorial approaches and personalized immune modulation is emphasized, offering valuable insights and directions for optimizing cancer immunotherapy strategies.

Frontiers in ImmunologyVol. 16
Sun Yat-sen University (CN), First People's Hospital of Foshan (CN), Panyu District Central Hospital (CN), Sun Yat-sen University Cancer Center (CN), Guangzhou Medical University (CN)
Guangzhou Medical University
Good health and well-being
Openalex Percentile: Top 88%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The role of immune checkpoint molecules in cancers — Lei Zhu, Mingqing Zhou, et al. · Frontiers in Immunology (2026) | TGRS Research Map | TGRS